99 studies found for:    "Sham injection"
Show Display Options
Rank Status Study
1 Completed
Has Results
A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)
Condition: Diabetic Macular Edema
Interventions: Drug: ocriplasmin;   Other: Sham injection
2 Completed
Has Results
A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
Conditions: Macular Edema;   Diabetic Mellitus;   Retinal Disease
Interventions: Drug: pegaptanib sodium;   Other: sham injection
3 Completed
Has Results
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: Ranibizumab injection 0.3 mg;   Drug: Ranibizumab injection 0.5 mg;   Drug: Sham injection
4 Completed
Has Results
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: Sham injection;   Drug: Ranibizumab injection 0.3 mg;   Drug: Ranibizumab injection 0.5 mg
5 Completed
Has Results
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Conditions: Proliferative Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide;   Behavioral: Sham injection;   Procedure: Focal/grid laser
6 Completed
Has Results
Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion
Conditions: Exudative Age-Related Macular Degeneration;   Focal Vitreomacular Adhesion
Interventions: Drug: Ocriplasmin;   Drug: Sham injection
7 Active, not recruiting Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy
Condition: Age-Related Macular Degeneration
Interventions: Drug: Fluocinolone Acetonide;   Drug: Sham Injection
8 Completed
Has Results
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
Conditions: Proliferative Diabetic Retinopathy;   Diabetic Traction Retinal Detachment;   Vitreous Hemorrhage
Interventions: Drug: Bevacizumab;   Procedure: Vitrectomy;   Device: Sham injection
9 Completed
Has Results
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: 700 µg Dexamethasone;   Drug: 350 µg Dexamethasone;   Other: Sham Injection
10 Completed
Has Results
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: 700 µg Dexamethasone;   Drug: 350 µg Dexamethasone;   Other: Sham Injection
11 Recruiting Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Intravitreal Aflibercept injection;   Drug: Sham injection;   Procedure: Half-fluence photodynamic therapy
12 Completed
Has Results
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Sham injection
13 Completed
Has Results
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Sham injection
14 Recruiting Optimization of Synvisc-One for Knee OA
Condition: Knee Osteoarthritis
Interventions: Device: Synvisc-One Injection;   Other: Sham Injection
15 Recruiting Phase II Combination Steroid and Anti-VEGF for Persistent DME
Condition: Diabetic Macular Edema
Interventions: Drug: intravitreal ranibizumab 0.3 mg;   Drug: dexamethasone intravitreal implant;   Procedure: Sham injection
16 Completed Vitamin A and Very Low Birthweight Babies (VitAL)
Conditions: Preterm Birth;   Retinopathy of Prematurity
Interventions: Drug: Aquasol A;   Drug: aquasol A;   Other: sham injection
17 Active, not recruiting Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole
Condition: Vitreomacular Adhesion Including Macular Hole
Interventions: Drug: Ocriplasmin;   Other: Sham injection
18 Recruiting Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: FAI insert;   Drug: Sham injection
19 Active, not recruiting A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion
Condition: Vitreomacular Adhesion
Interventions: Drug: A01016;   Drug: Sham injection
20 Recruiting Comparison of Platelet Rich Plasma and Alternative Therapies for the Treatment of Tennis Elbow (Lateral Epicondylitis)
Condition: Lateral Epicondylitis (Tennis Elbow)
Interventions: Other: Platelet Rich Plasma (PRP) Injection;   Other: Whole Blood Injection;   Other: Dry Needle Fenestration;   Other: Sham Injection

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years